"What started as a small but innovative dyestuffs factory in the Barmen district of Wuppertal is now a global enterprise with more than 110,000 employees. In the past 150 years, Bayer inventions ...

BAYER’S new deal to buy Monsanto breaks records not only due to its size but because ... were worked out for utilising the truly outstanding management of the concentration camp to the best advantage ...

Bayer executives were keen to stress to Fierce this summer that the German pharma giant’s appetite for dealmaking hasn’t been curbed by a groupwide restructuring. Its latest cancer-focused ...

Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Bill Anderson, CEO and Board Chairman of Bayer AG, speaks with reporters on Friday, Sept. 13, 2024, at the St. Louis Post ...

Bayer's move leaves Merck still out in front – with an approval for gefapixant for cough in Japan where the drug is known as Lyfnua – but clearly casts a shadow on the class as a whole.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

With the heart failure (HF) patient population rapidly expanding, the timing is right for Bayer’s Kerendia (finerenone). The nonsteroidal mineralocorticoid receptor antagonist (MRA) was approved ...

Bayer is targeting a broader use of Nubeqa in metastatic hormone-sensitive prostate (mHSPC) cancer with a combination free of chemotherapy. Bayer plans to seek the FDA’s blessing for Nubeqa plus ...

Bayer Leverkusen CEO Fernando Carro didn't grow up in football, but his outside-the-box thinking is turning the club into the ...

Bayer suspended the phase 3 trial for its factor XIa inhibitor asundexian late last year after the drug showed “inferior efficacy” at preventing strokes in patients with atrial fibrillation ...

“Though they don’t widely acknowledge it, they realize selling millions of gallons of product is a blunt and fading model,” Jason Miner, global head of agriculture at Bloomberg Intelligence, said of ...

Match ends, Borussia Mönchengladbach 2, Bayer 04 Leverkusen 3. Goal! Borussia Mönchengladbach 2, Bayer 04 Leverkusen 3. Florian Wirtz (Bayer 04 Leverkusen) right footed shot from very close ...